当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Azharuddin M Malik, Uwais Ashraf and Nasar Abdali
Neurocysticercosis is the commonest parasitic disease of the nervous system. Its clinical manifestations are highly variable ranging from asymptomatic disease to recurrent seizures and multisystem involvement. The imaging findings of neurocysticercosis although typical are not diagnostic for the disease and can be confused lesions of tuberculomas. To circumvent the diagnostic difficulty various serological tests have been tried. Most of the early serological tests were limited by low sensitivity and specificity for the diagnosis. Recently better antibody based assays like Enzyme Linked Immuno Electro Transfer Blot (EITB) have vastly improved the specificity of diagnosis, but sensitivity esp. in single cystic lesions still remains suboptimal. Further advances in the field of serodiagnosis of neurocysticercosis, especially focusing on validation of emerging techniques of diagnosis, will be required before the can be implemented for routine use.